In patients with ALS, baseline MGF mRNA in muscle biopsies was similar to that of healthy controls.
In plain wordsIn people with ALS, the body's own MGF level in muscle at baseline was similar to that of healthy people.
- Peptide
- MGF / PEG-MGF
- Outcome
- No significant changeBaseline MGF mRNA in muscle, ALS patients versus healthy controls
- Study
n: not reported in source
- Comparator
- Healthy controls
- Outcome group
- Muscle injury and repair · Nervous system and cognition
Source sentences
Patients with ALS had similar baseline levels of MGF and IGF-IEa mRNA to healthy controls
1 context sentence(design, population, supporting numbers)
We assessed the levels of MGF and IGF-IEa mRNA in muscle biopsy samples from healthy subjects and patients with ALS, before and after exercise.
This result measures the body's own MGF / PEG-MGF. Nobody was given the peptide. It is not evidence about taking it.